The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
A 20-year-old male with chronic myelogenous leukemia (CML) and severe bone marrow fibrosis underwent splenectomy, then ablative chemotherapy, followed by bone marrow transplantation from a histocompatible sister. The myelofibrosis completely resolved. Prompt marrow engraftment and disappearance of Philadelphia chromosome positive cells were documented. Therefore, the presence of marrow fibrosis which frequently accompanies CML is rapidly reversible following high dose chemotherapy and is not indicative of a hostile microenvironment which could preclude marrow transplantation for patients with CML and myelofibrosis.
D000328:Adult; D000493:Allopurinol / Q000008:administration & dosage; D001241:Aspirin / Q000008:administration & dosage; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005347:Fibroblasts / Q000473:pathology; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D008297:Male; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D013156:Splenectomy
D000493:Allopurinol; D002066:Busulfan; D001241:Aspirin